Français
Movember
Prostate Cancer Canada Network
Our Team
Board of Directors
Halifax/ Atlantic Region
Atlantic Region Launch
Halifax FDWR 2011
August 2011
September 2011
October 2011
Corp. Supporters
Careers at PCC
Privacy Policy
Ethics & Accountability
Testimonials
Where Does Your Dollar Go?
About the Prostate
Early Detection Guidelines
Prevention
Non-Cancerous Prostate Conditions
PSA
Prostate Cancer
What is Cancer?
What is Prostate Cancer?
Prostate Cancer Disease States
PCA3 Test
Prostate Cancer Facts
Statistics
Glossary
Resources
Treatment
Experimental and Alternative Therapies
P.C. Assessment Tools
Science Behind PCATs
Disclaimer
Risk Assessment Quiz
Risk Factor
Age
Diet
Environmental Factors
Family History
Ethnicity / Nationality
Weight
A History of Success
Research Success Stories
Pilot Grant Program
Pilot Grant FAQs
Grant Application Guidelines
Copyright & Trademark Notice
Research Grants From Previous Years
Apply for a Pilot Grant
Request for Applications
Clinician Scientist Award
Clinician Scientist Awards From Previous Years
Clinician-Scientist Award Application
Clinician-Scientist Award Guidelines
2012 Request for Applications: Clinician-Scientist Program
Progress and Final Report
Scientific Medical Community
SMAC Sign In
News Articles
PC Awareness Month
Prostate Cancer News
It's Our Time
Foundation Publications
News Releases
PSAs
The Faces of Prostate Cancer
Events
Movember
Father's Day Walk/Run
PCCN Conference
Tied Together
Wake Up Call Breakfast
Community Events
How to Support Us
Host an Information Session
Monthly Giving Program
Sponsor an Event
Naming a Research Grant
Volunteer
Advocacy
Campaign to Control Cancer
Shop PCC
Purchase Our Merchandise
GIVE NOW
Ways to Donate
Planned Giving
Monthly Giving Program
Donate by Phone, Mail or Fax
Gifts of Publicly Traded Securities
Charity Car Donation Program
Where Does Your Dollar Go?
Research Success Stories
Dr. Jeremy Squire
Dr. Fred Saad
Dr. Marek Los
Dr. Shana Kelley
Dr. Thomas Buckley
Dr. Kim Chi
Dr. Joseph L. Chin
Dr. Yves Fradet
Drs. Richard Choo and Laurence Klotz
Dr. Brad Nelson
Dr. Jim Xuan
Dr. Claude Labrie
For more information visit
www.movember.com
In The News
PSA Fitness (Power, Strength & Agility)
HALIFAX, N.S., January 16, 2012/CNW/ Prostate Cancer Canada Atlantic is proud to announce the launch of PSA Fitness (Power, Strength & Agility), a free nine week exercise program for men who have been diagnosed with prostate cancer. PSA Fitness, resistance training and yoga, is an important patient-centered therapy for prostate cancer survivors in Halifax.
TELUS donation to support Prostate Cancer Canada
Toronto, ON- January 13, 2012- On January 10th, Prostate Cancer Canada received a generous donation of $100,000 from TELUS at the launch of the TIEd Together exhibition. TELUS’ donation was made possible through the Canadian Football League Grey Cup cause marketing campaign. The donation will support Prostate Cancer Canada’s ongoing efforts to eliminate the disease through research, education, support and awareness.
Click For Information Archive
In Search of a New Prostate Cancer Biomarker
Dr. Jeremy Squire (2003 and 2005 Research Grants)
Prostatic Intraepithelial Neoplasia (PIN)
is a non cancerous prostate condition but it has the potential to turn into cancer. High grade PIN, in particular, is a significant risk factor for prostate cancer. Dr. Squire’s research focuses on the links between high grade PIN and prostate cancer and he has found a promising new biomarker that may help diagnose the cases of PIN that are most likely to turn into prostate cancer. This biomarker is called a telomere. Telomeres are structures found on the ends of chromosomes that protect chromosomes from mutations and play an important role in deciding the number of times a cell can divide.
Every time an older cell divides it loses a tiny piece of DNA from the telomere. This process is called telomere attrition and it can make the telomeres too short to work properly, which causes the chromosomes to rearrange and result in genetic mutations (which in turn lead to high grade PIN and prostate cancer).
Squire’s study looked at a group of 68 men with high grade PIN (but not prostate cancer) and compared the lengths of their telomeres. The study found several significant links between short telomere length and long term diagnosis of prostate cancer – suggesting that telomere attrition in PIN is the basis of genetic mutations that cause prostate cancer.
In collaboration with local nanotechnology experts, Dr. Squire is now looking for quick and cost effective ways to measure telomere length during biopsies.
Thanks for the follows! @RabyInstitute @THENUMBERUNEO @BBSupport @JackieManthorne @TELUS @ABJuniorCurling @PatientStories1 @healthfinder
Follow Us On Twitter
GIVE NOW!
Ethics and Accountability
About Prostate Cancer
Prostate Cancer News
Careers
Prostate Cancer Canada
2 Lombard Street, 3rd Floor, Toronto
Ontario M5C 1M1, Canada
info@prostatecancer.ca
Telephone: 416-441-2131
Toll-free: 1-888-255-0333
Fax: 416-441-2325
© 2011 - Prostate Cancer Canada - Charitable Registration Number: BN 89127 0944 RR0001
Design and Development
Inorbital